CASH FLOW
GlaxoSmithKline Pharmaceuticals Ltd.
BSE
Jun 02, 03:53
3271.55
-23.45 ( -0.71%)
Volume
8744
Prev. Close
3295.00
Open Price
3295.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 02, 03:44
3271.10
-27.50 ( -0.83%)
Volume
208862
Prev. Close
3298.60
Open Price
3298.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
3271.10 (124)
You can view the
Cash Flow
for the last 5 years.
|
ISIN No
|
INE159A01016
|
Market Cap. ( ₹ in Cr. )
|
55414.41
|
P/BV
|
33.13
|
Book Value ( ₹ )
|
98.74
|
|
BSE Code
|
500660
|
52 Week High/Low ( ₹ )
|
3398/1921
|
FV/ML
|
10/1
|
P/E(X)
|
59.74
|
|
NSE Code
|
GLAXOEQ
|
Book Closure
|
30/05/2025
|
EPS ( ₹ )
|
54.75
|
Div Yield (%)
|
1.65
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 1255.19 | 959.80 | 841.49 | 2475.65 | 723.10 |
| | | | | | |
| Net CashFlow From Operating Activities | 1289.91 | 582.02 | 484.23 | 810.75 | 577.93 |
| Net Cash Used In Investing Activities | -45.81 | 8.71 | 807.85 | -405.51 | 418.59 |
| Net Cash Used From Financing Activities | -769.42 | -561.50 | -1543.32 | -524.24 | -696.14 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 474.68 | 29.23 | -251.25 | -119.00 | 300.38 |
| Cash And Cash Equivalents Begin of Year | 64.17 | 34.94 | 286.19 | 405.19 | 104.81 |
| Cash And Cash Equivalents End Of Year | 538.85 | 64.17 | 34.94 | 286.19 | 405.19 |